PMV PharmaceuticalsPMVP
13F holders, Q1 2025 (March 31)55holders −15
1new positions
16sold out
3famous investors
$1.09avg. 13F price*
At the end of Q1 2025, 55 institutions reported holding PMV Pharmaceuticals Inc. (PMVP) in their 13F filings, down 15 from Q4 2024. 1 opened new positions and 16 sold out. The largest holders were Orbimed Advisors LLC ($7.1M), BML Capital Management, LLC ($4.1M) and Sio Capital Management, LLC ($4.1M). 3 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- PMV Pharmaceuticals Inc.
- CUSIP
- 69353Y103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 16 | $1.7M |
All 13F filers, Q4 2024 → Q1 2025: 1,877,268 shares bought and 3,516,163 shares sold, net −1,638,895 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 55 holders
| Orbimed Advisors LLC | 0.17% | No change | 6,475,291 | $7.1M |
| BML Capital Management, LLC | 3.31% | Add +8.1% | 3,747,612 | $4.1M |
| Sio Capital Management, LLC | 1.23% | Add +4.6% | 3,735,396 | $4.1M |
| ArrowMark Colorado Holdings LLC | 0.06% | Reduce -5.7% | 3,308,677 | $3.6M |
| PFM Health Sciences, LP | 0.28% | Add +58.8% | 3,301,942 | $3.6M |
| Euclidean Capital LLC | 1.08% | No change | 2,627,643 | $2.9M |
| Alkeon Capital Management LLC | 0.02% | Reduce -0.1% | 2,342,373 | $2.6M |
| Vanguard Group Inc. | 0.00% | Add +1.5% | 2,175,061 | $2.4M |
| Acadian Asset Management LLC | 0.01% | Reduce -1.5% | 2,047,177 | $2.2M |
| BlackRock, Inc. | 0.00% | Reduce -0.2% | 1,144,396 | $1.2M |
| D. E. Shaw & Co. | 0.00% | Reduce -7.3% | 949,726 | $1.0M |
| Stonepine Capital Management, LLC | 0.67% | Add +17.6% | 630,183 | $687K |
| Aldebaran Capital, LLC | 0.54% | Add +4.3% | 523,553 | $571K |
| Two Sigma Advisers, LP | 0.00% | Reduce -29.3% | 505,600 | $551K |
| Peapod Lane Capital LLC | 0.60% | Add +9.8% | 489,370 | $533K |
| Geode Capital Management, LLC | 0.00% | Add +2.1% | 430,792 | $470K |
| Two Sigma Investments, LP | 0.00% | Reduce -30.3% | 353,227 | $385K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -27.9% | 267,636 | $292K |
| RBF Capital, LLC | 0.02% | No change | 245,561 | $268K |
| State Street Corp. | 0.00% | No change | 157,578 | $172K |
| Millennium Management | 0.00% | Reduce -51.1% | 155,389 | $169K |
| UBS Group AG | 0.00% | Reduce -44.7% | 152,283 | $166K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -26.4% | 148,800 | $162K |
| Evoke Wealth, LLC | 0.00% | No change | 133,122 | $145K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -75.9% | 129,914 | $142K |
| Dimensional Fund Advisors LP | 0.00% | No change | 126,004 | $137K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -25.1% | 115,038 | $125K |
| Northern Trust Corp. | 0.00% | Add +0.0% | 107,346 | $117K |
| Walleye Capital LLC | 0.00% | Reduce -20.3% | 101,696 | $111K |
| ADAR1 Capital Management, LLC | 0.02% | No change | 101,008 | $110K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -25.6% | 90,263 | $98K |
| Panagora Asset Management Inc. | 0.00% | No change | 89,631 | $98K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -10.1% | 62,134 | $68K |
| Velan Capital Investment Management LP | 0.04% | No change | 35,000 | $38K |
| Bank of America Corp. | 0.00% | Reduce -22.1% | 34,706 | $38K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 33,600 | $37K |
| Barclays PLC | 0.00% | No change | 30,197 | $33K |
| HSBC Holdings PLC | 0.00% | Reduce -20.9% | 30,891 | $33K |
| Morgan Stanley | 0.00% | Reduce -32.8% | 28,066 | $31K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -34.9% | 22,900 | $25K |
| Squarepoint Ops LLC | 0.00% | Reduce -70.0% | 21,896 | $24K |
| Citigroup Inc. | 0.00% | Reduce -96.3% | 19,310 | $21K |
| Ameriprise Financial Inc. | 0.00% | Reduce -21.1% | 18,007 | $20K |
| Citadel Advisors | 0.00% | Reduce -86.9% | 14,120 | $15K |
| Independent Advisor Alliance | 0.00% | Reduce -0.1% | 12,500 | $14K |
| JPMorgan Chase & Co. | 0.00% | Reduce -53.4% | 11,449 | $12K |
| Group One Trading LLC | 0.00% | Reduce -24.6% | 11,296 | $12K |
| Wells Fargo & Company | 0.00% | New | 10,000 | $11K |
| Corient Private Wealth LP | 0.00% | No change | 10,000 | $11K |
| Public Employees Retirement System of Ohio | 0.00% | Reduce -57.6% | 2,092 | $2K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.8% | 720 | $785 |
| BNP Paribas Financial Markets | 0.00% | Reduce -28.7% | 544 | $593 |
| FMR LLC | 0.00% | Reduce -68.7% | 315 | $343 |
| Royal Bank of Canada | 0.00% | Reduce -99.0% | 384 | $0 |
"% of holder's portfolio" is PMVP's weight in each manager's 13F, not the share of PMV Pharmaceuticals Inc. the manager owns.